Luminary Therapeutics, Inc.
Luminary Therapeutics, Inc. is a small business in Minneapolis, MN registered on SAM.gov to bid on federal contracts. It has won 6 small business R&D awards worth $3.4 million through the SBIR and STTR programs since 2020, according to SBIR.gov.
- UEI
- MNKBAEZHWJS1
- CAGE code
- 8D9M3
- SAM.gov registration
- Active
Registration details
From SAM.gov's monthly public file dated Oct 5, 2026. If the business has updated its registration since, SAM.gov shows the newer details.
| Legal business name | Luminary Therapeutics, Inc. |
|---|---|
| Unique Entity ID (UEI) | MNKBAEZHWJS1 |
| CAGE code | 8D9M3 |
| Location | Minneapolis, MN |
| SAM.gov registration | Active through Mar 18, 2027 |
| Business started | 2019 |
| Primary NAICS code | 541714: Research and Development in Biotechnology (except Nanobiotechnology) |
| Website | www.luminarytx.com |
Certifications and business types
SAM.gov's public file from Oct 5, 2026 lists no SBA certification (8(a), HUBZone or WOSB) for Luminary Therapeutics, Inc.. The file sometimes leaves a certification out, and a newer one won't be in it yet: SBA's certification search and the firm's SAM.gov entry have the current list. SBA certifications let a business compete for set-aside contracts. See set-aside contracts explained.
SBIR and STTR awards
Luminary Therapeutics, Inc. has won 6 small business R&D awards worth $3.4 million through the SBIR and STTR programs since 2020, 1 of them Phase II. Funded by NIH.
| Awarded | Agency | Project | Amount |
|---|---|---|---|
| Sep 1, 2025 | NIH | SBIR Phase II Allogeneic BAFF Ligand Based CAR T Cells as a Novel Therapy for B Cell Malignancies | $1.5 million |
| Sep 13, 2024 | NIH | SBIR Phase I An allogeneic gamma/delta armored Dual-Targeting CAR with Split Costimulatory Domains to Target… | $399,256 |
| Aug 1, 2023 | NIH | SBIR Phase I Allogeneic BAFF Ligand Based CAR T-Cells as a Novel Therapy for Systemic Lupus Erythematous | $299,770 |
| Jul 1, 2023 | NIH | SBIR Phase I Allogeneic BAFF Ligand Based CAR T Cells as a Novel Therapy for B Cell Malignancies | $397,934 |
| Aug 1, 2021 | NIH | SBIR Phase I Simultaneous Targeting of Tumor and Stroma Cells to Enhance Solid Tumor CAR-T Cell Therapy | $399,658 |
| Sep 8, 2020 | NIH | SBIR Phase I MyD88 fusion protein with antigen specific T Cell therapy for enhanced response in solid tumors | $397,422 |
Award data from SBIR.gov. SBIR and STTR awards are grants or contracts for R&D, so some don't appear in its federal contract history.
Federal contract history
USAspending.gov shows no federal prime contracts for this UEI in the last five years. Its SBIR and STTR awards are listed above.
NAICS codes Luminary Therapeutics, Inc. is small under
On its SAM.gov registration, Luminary Therapeutics, Inc. meets the SBA size standard for these industries, so it can bid on small business set-asides that use them.
Open contracts in Luminary Therapeutics, Inc.'s NAICS codes
252 open federal opportunities on SAM.gov use one of Luminary Therapeutics, Inc.'s NAICS codes and are open to it: no set-aside, or, in the codes it is registered small under, a small business set-aside or one for a certification it holds. Here are a few, those in its primary code first (none of these are in Minnesota right now), then the soonest due.
- UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day
Event or sign-up Oct 14, 2026
- Protein ENGineering (PENG)
✦ DARPA's Defense Sciences Office wants teams to build a platform that can edit existing (endogenous) proteins inside living cells, without permanently changing DNA. It is a…
Due in 8 daysOct 19, 2026
- Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories
✦ NIH (NIDA) is running a sources sought notice, not a solicitation, to find companies that can run, consolidate or recompete NIH biorepositories for FY 2028.
Due in 9 daysOct 20, 2026
- Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories
✦ NIH (through NIDA) is asking small businesses whether they can run one or more NIH biorepositories (sample banks) for FY 2028, including the NIDA Center for Genetic Studies and…
Due in 9 daysOct 20, 2026
- NAWCWD Broad Agency Announcement
Due in 19 daysOct 30, 2026
Similar small businesses
Other small businesses of a similar size with the same primary NAICS code (541714) that have won federal contracts. None in Minnesota have yet, so these are in nearby states:
- GODX Inc, Madison, WI
Frequently asked questions
What is Luminary Therapeutics, Inc.'s CAGE code?
Luminary Therapeutics, Inc.'s CAGE code is 8D9M3. The Defense Logistics Agency assigns CAGE codes when a business registers on SAM.gov.
What is Luminary Therapeutics, Inc.'s UEI?
Luminary Therapeutics, Inc.'s Unique Entity ID (UEI) is MNKBAEZHWJS1. SAM.gov assigns the UEI, and it identifies the business across the federal government.
Is Luminary Therapeutics, Inc.'s SAM.gov registration active?
Yes, as of SAM.gov's public data from Oct 5, 2026, Luminary Therapeutics, Inc.'s registration is active through Mar 18, 2027. Registrations are renewed every year.
Is Luminary Therapeutics, Inc. a small business?
Luminary Therapeutics, Inc. is registered on SAM.gov as small under 2 NAICS codes, including its primary code, 541714. Size is set per NAICS code, so a business can be small for some contracts and not others.
Keep going
- Look up another business's CAGE code or UEI
- Check a SAM.gov registration's status
- How to become a government subcontractor
Registration details come from SAM.gov's public entity extract and contract figures from USAspending.gov. Contact names and street addresses are left out. To change these details, update the registration on SAM.gov. To report a mistake on this page, or to ask us to remove it, email hello@fedready.us with the page address; we reply within 2 business days. For a removal, write from an address at the company.